- Home
- ITRG vs MOLN Comparison
ITRG vs MOLN Comparison
Compare ITRG & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- MOLN
- Stock Information
- Founded
- ITRG 1997
- MOLN 2004
- Country
- ITRG Canada
- MOLN Switzerland
- Employees
- ITRG N/A
- MOLN N/A
- Industry
- ITRG Precious Metals
- MOLN
- Sector
- ITRG Basic Materials
- MOLN
- Exchange
- ITRG Nasdaq
- MOLN Nasdaq
- Market Cap
- ITRG 227.8M
- MOLN 183.2M
- IPO Year
- ITRG N/A
- MOLN 2021
- Fundamental
- Price
- ITRG $1.70
- MOLN $4.10
- Analyst Decision
- ITRG Strong Buy
- MOLN
- Analyst Count
- ITRG 1
- MOLN 0
- Target Price
- ITRG $2.75
- MOLN N/A
- AVG Volume (30 Days)
- ITRG 1.5M
- MOLN 25.8K
- Earning Date
- ITRG 05-14-2025
- MOLN 03-06-2025
- Dividend Yield
- ITRG N/A
- MOLN N/A
- EPS Growth
- ITRG N/A
- MOLN N/A
- EPS
- ITRG N/A
- MOLN N/A
- Revenue
- ITRG $30,350,000.00
- MOLN $5,484,562.00
- Revenue This Year
- ITRG $746.16
- MOLN N/A
- Revenue Next Year
- ITRG N/A
- MOLN $866.67
- P/E Ratio
- ITRG N/A
- MOLN N/A
- Revenue Growth
- ITRG N/A
- MOLN N/A
- 52 Week Low
- ITRG $0.73
- MOLN $3.36
- 52 Week High
- ITRG $1.88
- MOLN $12.70
- Technical
- Relative Strength Index (RSI)
- ITRG 54.74
- MOLN 52.08
- Support Level
- ITRG $1.61
- MOLN $3.79
- Resistance Level
- ITRG $1.95
- MOLN $4.27
- Average True Range (ATR)
- ITRG 0.11
- MOLN 0.27
- MACD
- ITRG -0.02
- MOLN 0.04
- Stochastic Oscillator
- ITRG 26.87
- MOLN 66.07
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.